Tapinarof Global Patent Coverage & Expiry Overview

Track protection status across key markets to assess launch feasibility.

Start your free 7-Day Trial! Book a demo to explore our global patent data.

It is formulated by 1 pharmaceutical company such as ORGANON LLC. It is marketed under 1 brand name, including VTAMA. Available in 1 different strength, such as 1%, and administered through 1 route including CREAM;TOPICAL.

Strategic Dashboard

info

insightsStrategic Insights

Sourcing & Feasibility

check_circle API availability: autorenew Loading API feasibility...

groups Licensing: 1 potential partners

calendar_todayUS Launch window: autorenew Loading launch window...

timeline Key Patent Barrier & Expiry Timeline

autorenew Loading patent barriers...

factoryGeneric Manufacturer Snapshot

autorenew Loading manufacturers...

gavelRisk & Opportunity Summary

dangerous Risk: autorenew Loading risk analysis...
watch_later Watch: autorenew Loading watch analysis...
rocket_launch Opportunity: autorenew Loading opportunity analysis...
flag
gavel
calendar_today
calendar_today

Access Global Patent Data

Stay ahead with worldwide patent expiry and latest updates.

✓ Comprehensive global patent expiry timelines
✓ Full patent family details and status updates
Unlock Global Patents

Orange Book Drug Approval Timeline

FDA approval history for this ingredient

NDA (New Drug Application) ANDA (Generic Application)

Access Global Exclusivity and Patent Expiry Extensions

Stay ahead with worldwide patent expiry insights, exclusivity data, and latest updates.

✓ Comprehensive global patent expiry timelines
✓ Full patent family details and status updates
✓ Latest exclusivity data and extensions
Unlock Global Access

US Orange Book Patents Expiration Timeline

Key expiration dates for US patents covering this ingredient

View Global Patents Expiration Timeline

Stay ahead with worldwide patent expiry insights, market data, and research updates.

✓ Comprehensive global patent expiry timelines
✓ Full patent family details and status updates
Unlock Global Patent Timeline

Orange Book Drug Strengths

Latest drug strengths approved by FDA

Strength Route of Administration Companies Latest Approval Date

Orange Book Patents

Patents approved by the FDA for the ingredient

Patent Number Publication Date Legal Status Patent Expiry Date
{"application_id":"38955","ingredient":"TAPINAROF","trade_name":"VTAMA","family_id":"e274245e99cd4fc38060","publication_number":"US11612573B2","cleaned_patent_number":"11612573","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2036-05-19","publication_date":"2023-03-28","legal_status":"Granted"} US11612573B2 28 Mar, 2023 Granted 19 May, 2036
{"application_id":"38954","ingredient":"TAPINAROF","trade_name":"VTAMA","family_id":"e274245e99cd4fc38060","publication_number":"US11622945B2","cleaned_patent_number":"11622945","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2036-05-19","publication_date":"2023-04-11","legal_status":"Granted"} US11622945B2 Formulation 11 Apr, 2023 Granted 19 May, 2036
{"application_id":"38950","ingredient":"TAPINAROF","trade_name":"VTAMA","family_id":"c43995f53a154dedb711","publication_number":"US10195160B2","cleaned_patent_number":"10195160","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2036-05-19","publication_date":"2019-02-05","legal_status":"Granted"} US10195160B2 Formulation 05 Feb, 2019 Granted 19 May, 2036
{"application_id":"38953","ingredient":"TAPINAROF","trade_name":"VTAMA","family_id":"c43995f53a154dedb711","publication_number":"US11458108B2","cleaned_patent_number":"11458108","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2036-05-19","publication_date":"2022-10-04","legal_status":"Granted"} US11458108B2 Formulation 04 Oct, 2022 Granted 19 May, 2036
{"application_id":"38951","ingredient":"TAPINAROF","trade_name":"VTAMA","family_id":"c43995f53a154dedb711","publication_number":"US10426743B2","cleaned_patent_number":"10426743","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2036-05-19","publication_date":"2019-10-01","legal_status":"Granted"} US10426743B2 01 Oct, 2019 Granted 19 May, 2036
{"application_id":"38952","ingredient":"TAPINAROF","trade_name":"VTAMA","family_id":"e274245e99cd4fc38060","publication_number":"US11617724B2","cleaned_patent_number":"11617724","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2036-05-19","publication_date":"2023-04-04","legal_status":"Granted"} US11617724B2 Formulation 04 Apr, 2023 Granted 19 May, 2036
{"application_id":"38976","ingredient":"TAPINAROF","trade_name":"VTAMA","family_id":"669d1730804948ffa8cb","publication_number":"US11597692B2","cleaned_patent_number":"11597692","drug_product_flag":"Y","drug_substance_flag":"Y","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2038-11-13","publication_date":"2023-03-07","legal_status":"Granted"} US11597692B2 Molecular Formulation 07 Mar, 2023 Granted 13 Nov, 2038
{"application_id":"38974","ingredient":"TAPINAROF","trade_name":"VTAMA","family_id":"669d1730804948ffa8cb","publication_number":"US10647649B2","cleaned_patent_number":"10647649","drug_product_flag":"-","drug_substance_flag":"Y","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2038-11-13","publication_date":"2020-05-12","legal_status":"Granted"} US10647649B2 Molecular 12 May, 2020 Granted 13 Nov, 2038
{"application_id":"139374","ingredient":"TAPINAROF","trade_name":"VTAMA","family_id":"","publication_number":"US11938099B2","cleaned_patent_number":"11938099","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2039-11-13","publication_date":"2024-03-26","legal_status":"Granted"} US11938099B2 26 Mar, 2024 Granted 13 Nov, 2039
{"application_id":"111741","ingredient":"TAPINAROF","trade_name":"VTAMA","family_id":"206414387f4e416db5fd","publication_number":"US11497718B2","cleaned_patent_number":"11497718","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2039-11-13","publication_date":"2022-11-15","legal_status":"Granted"} US11497718B2 15 Nov, 2022 Granted 13 Nov, 2039
{"application_id":"111740","ingredient":"TAPINAROF","trade_name":"VTAMA","family_id":"206414387f4e416db5fd","publication_number":"US11590088B2","cleaned_patent_number":"11590088","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2039-11-13","publication_date":"2023-02-28","legal_status":"Granted"} US11590088B2 28 Feb, 2023 Granted 13 Nov, 2039

Recent Clinical Trials

Latest clinical trials and research studies for this ingredient

NCT ID Title Status Phase Conditions Start Date Completion Date

API Suppliers/Manufacturer (Branded/Generic companies)

Manufacturing Locations

View Complete Supplier List

Unlock access to all suppliers of Tapinarof

✓ Access a comprehensive list of global suppliers
✓ Get information on each supplier
Unlock Suppliers

Note: Patent expirations and exclusivity timelines are dynamic and may shift based on litigation, regulatory extensions, and maintenance filings. Regular monitoring is advised.

GreyB © 2025 Elixir. All rights reserved.